Description

Co-Sentor (Losartan Potassium and Hydrochlorothiazide) Coated Tablets 100 mg/12.5 mg. №30

Ingredients

Each tablet contains 100 mg of losartan potassium and 12.5 mg of hydrochlorothiazide.

Mechanism of Action

Losartan works by relaxing blood vessels, promoting smoother blood flow. Hydrochlorothiazide aids in eliminating excess salt and water from the body, collectively reducing blood pressure.

Pharmacological Properties

The combination of losartan potassium and hydrochlorothiazide in Co-Sentor tablets effectively lowers blood pressure by enhancing vasodilation and promoting diuresis.

Indications for Use

Co-Sentor tablets are indicated for the treatment of hypertension. They help reduce blood pressure levels, thereby lowering the risks of strokes, heart attacks, and kidney issues.

Contraindications

Avoid Co-Sentor if allergic to any components, pregnant, or suffering from severe kidney disease. Consult your healthcare provider regarding your medical history before initiating this treatment.

Side Effects

Common side effects may include dizziness, fatigue, and increased urination. Notify your doctor if any adverse reactions occur.

Usage Instructions

Take one tablet of Co-Sentor daily as directed by your healthcare provider. The medication can be consumed with or without food. Do not discontinue treatment without medical advice.

Benefits Compared to Analogues

Studies have demonstrated the superior efficacy of the losartan potassium and hydrochlorothiazide combination in Co-Sentor tablets over monotherapy for hypertension management.

Suitable Patient Groups

Co-Sentor is suitable for adult patients with hypertension. Dosage adjustments may be necessary for specific patient populations such as the elderly or those with hepatic impairment.

Storage and Shelf Life

Store Co-Sentor tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired medication.

Packaging Description

Each package of Co-Sentor contains 30 coated tablets of 100 mg losartan potassium and 12.5 mg hydrochlorothiazide.

Clinical Evidence and Proven Effectiveness

Studies have confirmed the efficacy of Co-Sentor in reducing blood pressure levels. Research published in the Journal of Clinical Hypertension highlighted the enhanced effectiveness of the losartan and hydrochlorothiazide combination therapy compared to monotherapy in hypertensive patients.